New York, NY – September 3, 2020 -- InvestorsHub NewsWire – Traders News Source, a leading independent equity research and corporate access firm focused on small cap growth companies issues new research reports.

Cerebain Biotech Corp. (OTCPINK: CBBT) a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device and a synthetic drug solution, has entered into a Letter of Intent to purchase the assets of PKG, Inc. (PKG). PKG, Inc. is a leading contract design, developer, and manufacturing company for system-level devices with expertise in human-machine interfaces focusing on healthcare, industrial, aerospace and government products.

Oncologix Tech, Inc. (OTCPINK: OCLG) is a diversified medical holding company that operates and manufactures Class II medical device products, delivers Personal Health Care Services, and sells and distributes Durable and Home Medical Equipment. For its clients, Oncologix provides FDA approved medical devices, state licensed healthcare services, and medical products and technologies.

See our “can’t miss” full report with no obligation READ MORE
Copy and paste to browser may be required- https://tradersnewssource.com/potential-home-run-stock/

NIO Limited (NYSE: NIO), a Chinese manufacturer of autonomous vehicles, saw its shares drop 4% in Friday trading after the company announced an offering of 75 million American depositary shares. The stock had surged to US$19.88 on Thursday, a level that could help the firm raise between US$1.5 billion and US$1.7 billion. Sales of EV cars are expected to triple by 2025, from an expected 1.1 million this year, the association forecasts.

Opko Health, Inc. (NASDAQ: OPK) is a health-care services company whose stock has risen more than 300% since early April, in part due to investor excitement about the NFL Covid 19 testing agreement signed last month. The company shares have been struggling recently as OPK is investigating several likely false positive Covid-19 tests results from National Football League players and personnel that affected multiple teams.

Our full comprehensive report is available with no obligation READ MORE
Copy and paste to browser may be required –  https://tradersnewssource.com/potential-home-run-stock/



Disclosure
 
Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps.
 
TNS LLC has listed if any, all compensation in the linked full report
 
PRESS RELEASE PROCEDURES
 
The non-sponsored content contained herein has been prepared by a writer (the "Author"). Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS.
 
NO WARRANTY
 
TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
 
NOT AN OFFERING
 
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.
 
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com
 

CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source
 

Oncologix Tech (CE) (USOTC:OCLG)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Oncologix Tech (CE) Charts.
Oncologix Tech (CE) (USOTC:OCLG)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Oncologix Tech (CE) Charts.